Share
Title
Bringing curative genetic interventions for HIV and sickle-cell disease to resource-limited settings (HIV Cure & Gene Therapy Forum) (CME)
Code
SY44
Session Type
Symposium
Track
Not applicable
Channel
IAS+
Date Time
20 July 15:30- 17:00
Local Date Time
15:30 - 17:00 W. Europe Daylight Time
Co-Chairs:
Mark R. DYBUL, Georgetown University, United States
Jennifer ADAIR, Fred Hutchinson Cancer Research Center, United States
Moses SUPERCHARGER, Uganda

The moderators of this session are actively seeking to move cell and gene therapies into resource-limited parts of the world. The panelists will first briefly describe efforts designed to make this happen, and then discuss how to best engage key stakeholders in the future so that safe, durable, and accessible cures for HIV and sickle cell disease will be available to all of those in need.

3 min
 Moderators introduction
Jennifer ADAIR, Fred Hutchinson Cancer Research Center, United States
Mark R. DYBUL, Georgetown University, United States
Moses SUPERCHARGER, Uganda
5 min
 Towards Sustainable and Affordable Access of Curative Genetic Interventions for all that need them
Boro DROPULIC, Caring Cross, United States
PDF
5 min
 Development of in vivo gene therapies for HIV and SCD
Keith HOOTS, National Institutes of Health (NIH), United States
5 min
 Development and distribution of in vivo gene therapies for SCD
Susan STEVENSON, NIBR, United States
5 min
 Advocacy for sickle cell disease
Evelyn Harlow MWESIGWA, Ministry of Health of Uganda and Sickle Cell Network Uganda, Uganda
5 min
 Promotion of HIV cure research through diverse stakeholder engagement
Izukanji SIKAZWE, Centre for Infectious Disease Research in Zambia, Zambia
PDF
52 min
 Panel discussion
Jennifer ADAIR, Fred Hutchinson Cancer Research Center, United States
Evelyn Harlow MWESIGWA, Ministry of Health of Uganda and Sickle Cell Network Uganda, Uganda
Boro DROPULIC, Caring Cross, United States
Susan STEVENSON, NIBR, United States
Mark R. DYBUL, Georgetown University, United States
Keith HOOTS, National Institutes of Health (NIH), United States
Izukanji SIKAZWE, Centre for Infectious Disease Research in Zambia, Zambia
Moses SUPERCHARGER, Uganda
5 min
 Guest closing remarks
Francis COLLINS, National Institute of Health, United States

5 min
 Closing remarks
Sharon LEWIN, University of Melbourne, Australia